🇺🇸 Tacrolimus, Accord in United States
59 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 59
Most-reported reactions
- Nausea — 10 reports (16.95%)
- Product Substitution Issue — 8 reports (13.56%)
- Pyrexia — 7 reports (11.86%)
- Diarrhoea — 6 reports (10.17%)
- Off Label Use — 6 reports (10.17%)
- Vomiting — 6 reports (10.17%)
- Drug Level Decreased — 4 reports (6.78%)
- Headache — 4 reports (6.78%)
- Hospitalisation — 4 reports (6.78%)
- Myocardial Infarction — 4 reports (6.78%)
Other Immunology approved in United States
Frequently asked questions
Is Tacrolimus, Accord approved in United States?
Tacrolimus, Accord does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Tacrolimus, Accord in United States?
University of Cincinnati is the originator. The local marketing authorisation holder may differ — check the official source linked above.